Premium
Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?
Author(s) -
Patel Jashbhai K.,
Nemoto Takuma,
Vezeridis Michael,
Petrelli Nicholas,
Suh Okhee,
Dao Thomas L.
Publication year - 1986
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19860201)57:3<567::aid-cncr2820570328>3.0.co;2-y
Subject(s) - medicine , metastatic breast cancer , breast cancer , hormonal therapy , chemotherapy , palliative care , retrospective cohort study , palliative treatment , oncology , overall survival , palliative therapy , treatment modality , metastasis , hormone therapy , cancer , surgery , nursing
A retrospective review of 483 women who had metastatic breast cancer and were treated between 1942 and 1975 was carried out to examine the effects of improving and aggressive palliative modalities on patient survival. There was a steady increase in the proportion of patients treated by chemotherapy and/or hormonal ablative therapy. Additive hormonal therapy, irradiation, and surgery for palliation decreased in frequency during the same period. Survival time from the first recurrence did not appear to increase in these patients over the period of this study. In spite of increasingly sophisticated palliative therapies, the survival time of patients with metastasis did not appear to be significantly prolonged.